Department of Oral and Maxillofacial Surgery, Leiden University Medical Center, Leiden, The Netherlands.
J Craniomaxillofac Surg. 2011 Jan;39(1):69-72. doi: 10.1016/j.jcms.2010.03.022.
Bisphosphonates are used in the management of metastatic bone disease, Paget's disease of bone and osteoporosis. A long-term complication of these drugs is bisphosphonate-related osteonecrosis of the jaws (BRONJ). Treatment of BRONJ can be quite challenging, and remains a topic of debate. We report the case of a 74-year-old woman who had used Fosamax(®) (alendronate sodium) orally for four years. After 3½ years she developed pain, swelling, and a fistula in the left mandible. After exploration and sequestrectomy in combination with antibiotic treatment, osteolysis with a pathological fracture developed. Given the extent of the disorder and a decrease in complaints after the surgery, a non-surgical approach was chosen with continuation of the antibiotic treatment for 10 weeks, a soft diet and not wearing of dentures. During follow-up complaints subsided, the intra-oral fistula disappeared and the fracture healed. This is the first report of healing of a BRONJ patient stage III with pathological fracture. It illustrates the remaining healing potential of the bisphosphonate-treated bone.
双膦酸盐用于治疗转移性骨病、佩吉特病和骨质疏松症。这些药物的长期并发症是双膦酸盐相关的下颌骨坏死(BRONJ)。BRONJ 的治疗极具挑战性,仍是一个争议性话题。我们报告了一例 74 岁女性患者,她曾口服福善美(®)(阿仑膦酸钠)四年。三年半后,她的左下颌出现疼痛、肿胀和瘘管。在进行探查和清创术联合抗生素治疗后,出现了骨溶解和病理性骨折。鉴于病情的严重程度和手术后症状的减轻,选择了非手术方法,继续抗生素治疗 10 周,采用软食和不戴假牙。在随访期间,症状缓解,口腔内瘘管消失,骨折愈合。这是首例报告 BRONJ 患者 III 期并病理性骨折愈合的病例。它说明了接受双膦酸盐治疗的骨骼仍有愈合的潜力。